Development of therapeutic guidelines MCQs With Answer

Introduction: Development of therapeutic guidelines is a critical skill for M.Pharm students preparing to influence clinical decision-making and optimize patient outcomes. This blog provides focused multiple-choice questions that explore the methodology, appraisal, implementation, and updating of therapeutic guidelines. Questions emphasize evidence synthesis, grading systems, stakeholder engagement, conflict-of-interest management, economic evaluation, and practical challenges in local adaptation. Designed for advanced pharmacy learners, the quiz reinforces both conceptual understanding and applied judgment necessary for guideline development, evaluation, and clinical translation. Use these MCQs to test knowledge, identify gaps, and build competence in producing and implementing trustworthy, evidence-based therapeutic guidelines in hospital and community settings.

Q1. Which sequence best represents the standard steps in developing a therapeutic guideline?

• Define scope, conduct systematic review, grade evidence, draft recommendations, external review, update plan
• Write recommendations, search literature selectively, implement, monitor
• Conduct surveys of clinicians, form opinions, publish
• Perform cost analysis first, then write clinical advice

Correct Answer: Define scope, conduct systematic review, grade evidence, draft recommendations, external review, update plan

Q2. In framing a clinical question for evidence review, PICO stands for which elements?

• Population, Intervention, Comparator, Outcome
• Patient, Investigation, Control, Observation
• Procedure, Indication, Cost, Outcome
• Population, Index test, Case series, Outcome

Correct Answer: Population, Intervention, Comparator, Outcome

Q3. The GRADE approach is primarily used to assess which aspects of guideline recommendations?

• Quality of evidence and strength of recommendations
• Cost-effectiveness and budget impact
• Study design types only
• Patient satisfaction and adherence metrics

Correct Answer: Quality of evidence and strength of recommendations

Q4. Which of the following is NOT one of the AGREE II instrument domains for guideline appraisal?

• Scope and purpose
• Stakeholder involvement
• Editorial independence
• Cost-effectiveness analysis

Correct Answer: Cost-effectiveness analysis

Q5. For synthesizing clinical trial data to inform guideline recommendations, the most rigorous method is:

• Systematic review with meta-analysis
• Single high-quality randomized trial
• Expert opinion consensus
• Non-systematic narrative review

Correct Answer: Systematic review with meta-analysis

Q6. The Delphi technique is best described as a method for:

• Structured consensus building among experts using iterative surveys
• Randomized allocation of guideline panel members
• Rapid literature searching with no feedback rounds
• Laboratory-based clinical validation

Correct Answer: Structured consensus building among experts using iterative surveys

Q7. Which strategy is most important to manage conflicts of interest in guideline development?

• Full disclosure with transparent management plans and recusal where appropriate
• Allowing industry representatives to draft recommendations directly
• Ignoring minor financial ties to speed up development
• Keeping conflicts confidential to avoid controversy

Correct Answer: Full disclosure with transparent management plans and recusal where appropriate

Q8. A practical recommendation for how often therapeutic guidelines should be updated is:

• Every 3 years or sooner if significant new evidence emerges
• Never; once published they remain valid indefinitely
• Only when funding is available
• Every 10 years regardless of new data

Correct Answer: Every 3 years or sooner if significant new evidence emerges

Q9. A “strong” recommendation in a guideline typically indicates:

• Benefits clearly outweigh risks for most patients and it should be followed in most circumstances
• Evidence is very uncertain and clinician judgment is primary
• Recommendation is optional with no expected benefit
• Only applicable in research settings

Correct Answer: Benefits clearly outweigh risks for most patients and it should be followed in most circumstances

Q10. The PRISMA statement is a reporting guideline for which type of study?

• Systematic reviews and meta-analyses
• Randomized controlled trials
• Case-control observational studies
• Qualitative interviews

Correct Answer: Systematic reviews and meta-analyses

Q11. Which type of economic evaluation measures outcomes using quality-adjusted life years (QALYs)?

• Cost-utility analysis
• Cost-minimization analysis
• Cost-of-illness study
• Budget impact analysis

Correct Answer: Cost-utility analysis

Q12. Which instrument is widely recommended to assess the methodological quality and transparency of clinical practice guidelines?

• AGREE II
• CONSORT
• STROBE
• CARE

Correct Answer: AGREE II

Q13. When adapting an international guideline to a low-resource local setting, the most important local considerations are:

• Disease prevalence, healthcare resources, cultural factors, and feasibility of implementation
• Keeping the guideline exactly as the original regardless of context
• Only the medication brand names used abroad
• Translation accuracy without clinical modification

Correct Answer: Disease prevalence, healthcare resources, cultural factors, and feasibility of implementation

Q14. The primary aim of a therapeutic guideline is to:

• Standardize clinical care using best available evidence to improve patient outcomes and safety
• Replace clinician judgment entirely
• Enforce hospital policy without consideration of evidence
• Maximize pharmaceutical sales

Correct Answer: Standardize clinical care using best available evidence to improve patient outcomes and safety

Q15. Which metric is most useful to evaluate early implementation success of a new guideline?

• Adherence rates to recommended practices and related patient outcomes
• Number of guideline pages printed
• Number of expert meetings held
• Time taken to publish the guideline

Correct Answer: Adherence rates to recommended practices and related patient outcomes

Q16. For creating dosing recommendations in pediatric therapeutic guidelines, which evidence is essential?

• Age-specific pharmacokinetic/pharmacodynamic data and pediatric clinical trials or modeled dosing studies
• Adult dosing simply scaled by weight without PK data
• Only expert opinion from adult clinicians
• Information on adult adverse events only

Correct Answer: Age-specific pharmacokinetic/pharmacodynamic data and pediatric clinical trials or modeled dosing studies

Q17. Which factor commonly acts as a barrier to guideline adherence among prescribers?

• Complexity of recommendations and lack of clarity or feasibility
• Too few citations in the reference list
• High quality systematic reviews supporting the guideline
• Patient demand matching guideline advice

Correct Answer: Complexity of recommendations and lack of clarity or feasibility

Q18. A core principle of antibiotic stewardship guidelines is:

• Prefer narrow-spectrum agents guided by culture and susceptibility when possible
• Always choose the newest broad-spectrum antibiotic
• Use antibiotics for viral infections to prevent complications
• Avoid diagnostic testing to speed treatment

Correct Answer: Prefer narrow-spectrum agents guided by culture and susceptibility when possible

Q19. In the hierarchy of clinical evidence, which provides the highest level of evidence for treatment effect?

• Systematic review or meta-analysis of randomized controlled trials
• Single case report with a dramatic outcome
• Expert committee opinion without systematic review
• Observational cohort study

Correct Answer: Systematic review or meta-analysis of randomized controlled trials

Q20. When wording a recommendation, the practical difference between “strong” and “conditional” is best described as:

• “Strong” applies to most patients as a general rule; “conditional” requires clinician-patient shared decision-making and consideration of patient values
• “Strong” means optional; “conditional” means mandatory
• “Strong” recommendations are for research only; “conditional” are for clinical use
• There is no practical difference; terms are interchangeable

Correct Answer: “Strong” applies to most patients as a general rule; “conditional” requires clinician-patient shared decision-making and consideration of patient values

Download